Dexilant | Dexlansoprazole is a proton pump inhibitor medicine marketed by Takeda Pharmaceuticals for treating and reducing the side effects of gastroesophageal reflux disease (GERD). Dexilant may be prescribed to patients for the following:
reducing acid in the esophagus aiding in the healing process of a damaged esophagus preventing acid reflux
Dexilant and other proton pump inhibitors may also be used for preventing and treating stomach ulcers or symptoms of Zollinger-Ellison syndrome. Dexilant works by interacting with enzymes in the stomach that are responsible for creating acid. Dexilant interferes with the production of acid and reduces levels of acid which may have previously been harmful to the stomach lining or esophagus. Preventing further damage of these areas can allow them to heal properly.